TY - JOUR
T1 - Neuroimaging and Biosample Collection in the Toronto Adolescent and Youth Cohort Study
T2 - Rationale, Methods, and Early Data
AU - Dickie, Erin W
AU - Ameis, Stephanie H
AU - TAY Cohort Study Team
AU - Boileau, Isabelle
AU - Diaconescu, Andreea O
AU - Felsky, Daniel
AU - Goldstein, Benjamin I
AU - Gonçalves, Vanessa
AU - Griffiths, John D
AU - Haltigan, John D
AU - Husain, Muhammad O
AU - Rubin-Kahana, Dafna S
AU - Iftikhar, Myera
AU - Jani, Melanie
AU - Lai, Meng-Chuan
AU - Lin, Hsiang-Yuan
AU - MacIntosh, Bradley J
AU - Wheeler, Anne L
AU - Vasdev, Neil
AU - Vieira, Erica
AU - Ahmadzadeh, Ghazaleh
AU - Heyland, Lindsay
AU - Mohan, Akshay
AU - Ogunsanya, Feyi
AU - Oliver, Lindsay D
AU - Zhu, Cherrie
AU - Wong, Jimmy K Y
AU - Charlton, Colleen
AU - Truong, Jennifer
AU - Yu, Lujia
AU - Kelly, Rachel
AU - Cleverley, Kristin
AU - Courtney, Darren B
AU - Foussias, George
AU - Hawke, Lisa D
AU - Hill, Sean
AU - Kozloff, Nicole
AU - Polillo, Alexia
AU - Rotenberg, Martin
AU - Quilty, Lena C
AU - Tempelaar, Wanda
AU - Wang, Wei
AU - Nikolova, Yuliya S
AU - Voineskos, Aristotle N
N1 - Publisher Copyright:
© 2023 Society of Biological Psychiatry
PY - 2024/3
Y1 - 2024/3
N2 - BACKGROUND: The Toronto Adolescent and Youth (TAY) Cohort Study will characterize the neurobiological trajectories of psychosis spectrum symptoms, functioning, and suicidality (i.e., suicidal thoughts and behaviors) in youth seeking mental health care. Here, we present the neuroimaging and biosample component of the protocol. We also present feasibility and quality control metrics for the baseline sample collected thus far.METHODS: The current study includes youths (ages 11-24 years) who were referred to child and youth mental health services within a large tertiary care center in Toronto, Ontario, Canada, with target recruitment of 1500 participants. Participants were offered the opportunity to provide any or all of the following: 1) 1-hour magnetic resonance imaging (MRI) scan (electroencephalography if ineligible for or declined MRI), 2) blood sample for genomic and proteomic data (or saliva if blood collection was declined or not feasible) and urine sample, and 3) heart rate recording to assess respiratory sinus arrhythmia.RESULTS: Of the first 417 participants who consented to participate between May 4, 2021, and February 2, 2023, 412 agreed to participate in the imaging and biosample protocol. Of these, 334 completed imaging, 341 provided a biosample, 338 completed respiratory sinus arrhythmia, and 316 completed all 3. Following quality control, data usability was high (MRI: T1-weighted 99%, diffusion-weighted imaging 99%, arterial spin labeling 90%, resting-state functional MRI 95%, task functional MRI 90%; electroencephalography: 83%; respiratory sinus arrhythmia: 99%).CONCLUSIONS: The high consent rates, good completion rates, and high data usability reported here demonstrate the feasibility of collecting and using brain imaging and biosamples in a large clinical cohort of youths seeking mental health care.
AB - BACKGROUND: The Toronto Adolescent and Youth (TAY) Cohort Study will characterize the neurobiological trajectories of psychosis spectrum symptoms, functioning, and suicidality (i.e., suicidal thoughts and behaviors) in youth seeking mental health care. Here, we present the neuroimaging and biosample component of the protocol. We also present feasibility and quality control metrics for the baseline sample collected thus far.METHODS: The current study includes youths (ages 11-24 years) who were referred to child and youth mental health services within a large tertiary care center in Toronto, Ontario, Canada, with target recruitment of 1500 participants. Participants were offered the opportunity to provide any or all of the following: 1) 1-hour magnetic resonance imaging (MRI) scan (electroencephalography if ineligible for or declined MRI), 2) blood sample for genomic and proteomic data (or saliva if blood collection was declined or not feasible) and urine sample, and 3) heart rate recording to assess respiratory sinus arrhythmia.RESULTS: Of the first 417 participants who consented to participate between May 4, 2021, and February 2, 2023, 412 agreed to participate in the imaging and biosample protocol. Of these, 334 completed imaging, 341 provided a biosample, 338 completed respiratory sinus arrhythmia, and 316 completed all 3. Following quality control, data usability was high (MRI: T1-weighted 99%, diffusion-weighted imaging 99%, arterial spin labeling 90%, resting-state functional MRI 95%, task functional MRI 90%; electroencephalography: 83%; respiratory sinus arrhythmia: 99%).CONCLUSIONS: The high consent rates, good completion rates, and high data usability reported here demonstrate the feasibility of collecting and using brain imaging and biosamples in a large clinical cohort of youths seeking mental health care.
UR - http://www.scopus.com/inward/record.url?scp=85184076205&partnerID=8YFLogxK
U2 - 10.1016/j.bpsc.2023.10.013
DO - 10.1016/j.bpsc.2023.10.013
M3 - Article
C2 - 37979944
SN - 2451-9022
VL - 9
SP - 275
EP - 284
JO - Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
JF - Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
IS - 3
ER -